Nanjing Yunqiao Purui Biotechnology Co., Ltd. 22
  • Home

  • About Us

      • Our Company

      • Our Leadership

      • Our History

  • Preclinical Study

      • Target Discovery and Validation

        • Molecule Biology

        • Cell Function

        • Immunoassays

        • In Vitro Drug Screening

      • In Vivo Pharmacology

        • Oncology

          • CDX Subcutaneous Tumor Model
          • CDX Orthotopic Tumor Model
          • CDX Metastatic Tumor Model
          • PDX Tumor Model
          • Resistant Tumor Model
          • Cancer Supportive Care Model
          • Tumor Rat Model
        • Immuno-Oncology

        • Inflammation and Autoimmune

        • Cardiovascular Disease

        • Metabolic Disease

      • ADME-DMPK

        • In vitro ADME

        • In vivo DMPK

        • Bioanalysis

        • Bioequivalence

      • Non-GLP Toxicity

        • MTD Test

        • DRF Test

        • Immunotoxicity

        • Local toxicity

        • Genotoxicity

      • Pathology

        • Histopathology

        • IHC/IF

        • Tissue Microarray

        • Clinical Pathology

  • Medical Device Testing

      • Implantation Test

      • Irritation Test

      • Sensitization Test

      • Pyrogen Test

  • Translational Medicine

      • Precision Oncology

        • Precision drug screening

        • Biomarker Development

  • News and Publication

      • Company News

      • Industry News

      • Publications

  • Contact Us

      • Contact Info

      • Careers

      • Online Message

CN/EN

技术平台

技术平台

New Drug R & D Technology Platform

  • Target Discovery and Validation Target Discovery and Validation

    • Molecule Biology Molecule Biology

    • Cell Function Cell Function

    • Immuno-assays Immuno-assays

    • In Vitro Drug Screening In Vitro Drug Screening

  • In Vivo Pharmacology In Vivo Pharmacology

    • Oncology Oncology

    • Immuno-Oncology Immuno-Oncology

    • Inflammation and Autoimmune Inflammation and Autoimmune

    • Cardiovascular Disease Cardiovascular Disease

    • Metabolic Disease Metabolic Disease

  • ADME-DMPK ADME-DMPK

    • In vitro ADME In vitro ADME

    • In vivo DMPK In vivo DMPK

    • Bioanalysis Bioanalysis

    • Bioequivalence Bioequivalence

  • Non-GLP Toxicity Non-GLP Toxicity

    • MTD Test MTD Test

    • DRF Test DRF Test

    • Immunotoxicity Immunotoxicity

    • Local toxicity Local toxicity

    • Genotoxicity Genotoxicity

  • Pathology Pathology

    • Histopathology Histopathology

    • IHC/IF IHC/IF

    • Tissue Microarray Tissue Microarray

    • Clinical Pathology Clinical Pathology

+

In vitro ADME

+

In vivo DMPK

+

Bioanalysis

+

Bioequivalence

< 1 > proceed page

联科

Official Public Number

Official Public Number

Business License
  • Home

  • About Us

    • Our Company

    • Our Leadership

    • Our History

  • Preclinical Study

    • Target Discovery and Validation

      • Molecule Biology

      • Cell Function

      • Immunoassays

      • In Vitro Drug Screening

    • In Vivo Pharmacology

      • Oncology

      • Immuno-Oncology

      • Inflammation and Autoimmune

      • Cardiovascular Disease

      • Metabolic Disease

    • ADME-DMPK

      • In vitro ADME

      • In vivo DMPK

      • Bioanalysis

      • Bioequivalence

    • Non-GLP Toxicity

      • MTD Test

      • DRF Test

      • Immunotoxicity

      • Local toxicity

      • Genotoxicity

    • Pathology

      • Histopathology

      • IHC/IF

      • Tissue Microarray

      • Clinical Pathology

  • Medical Device Testing

    • Implantation Test

    • Irritation Test

    • Sensitization Test

    • Pyrogen Test

  • Translational Medicine

    • Precision Oncology

      • Precision drug screening

      • Biomarker Development

  • News and Publication

    • Company News

    • Industry News

    • Publications

  • Contact Us

    • Contact Info

    • Careers

    • Online Message

Copyright©2023 Nanjing Yunqiao Purui Biotechnology Co., Ltd.

Website Construction: Power of Chinese Enterprises Nanjing |Label

contact Message
tel 18551794303
tel ysun@clinbridgebio.com
qcode Focus on us
top Top